Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update

<p>Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programs Cash position expected to fund operations into second quarter of 2025 Two Phase 1 clinical trials of lead program, TIDAL-01, in several solid tumor Indications ongoing SAN DIEGO, Sept. 01, 2023 (GLOBE NEWSWIRE) — Turnstone Biologics […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/turnstone-biologics-corp-reports-second-quarter-2023-financial-results-and-provides-business-update/">Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>